Carlo Maria Alfieri
Overview
Explore the profile of Carlo Maria Alfieri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
101
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Mattinzoli D, Turolo S, Alfieri C, Ikehata M, Caldiroli L, Armelloni S, et al.
J Clin Med
. 2022 Dec;
11(23).
PMID: 36498673
Fibroblast growth factor 23 (FGF23) concentrations rise after the early stages of chronic kidney disease (CKD). FGF23 is involved in inflammatory reactions closely associated with an incremented risk of cardiovascular...
12.
Mattinzoli D, Cacioppo M, Ikehata M, Armelloni S, Alfieri C, Castellano G, et al.
Mater Today Bio
. 2022 Oct;
16:100286.
PMID: 36186846
Irinotecan (CTP-11) is one of the standard therapies for colorectal cancer (CRC). CTP-11 is enzymatically converted to the hydrophobic 7-ethyl-10-hydroxycamptothecin (SN38), a one hundred-fold more active metabolite. Conjugation of hydrophobic...
13.
Colucci V, Gallo P, Simone S, Morrone L, Alfieri C, Gesualdo L, et al.
Front Med (Lausanne)
. 2022 Oct;
9:966038.
PMID: 36186783
Background: The nephrectomy for donation reduces the renal parenchyma and glomerular filtration rate (GFR). It is important to understand the clinical consequences of kidney donation by a living donor. Methods:...
14.
Campise M, Alfieri C, Benedetti M, Perna A, Miglio R, Molinari P, et al.
Vaccines (Basel)
. 2022 Jul;
10(7).
PMID: 35891153
Kidney transplant recipients are a vulnerable population at risk of a life-threatening COVID-19 infection with an incidence of death four-times higher than in the general population. The availability of mRNA...
15.
Siddi M, Molinari P, Alfieri C, Tangredi M, Lunghi G, Colombo E, et al.
Pathogens
. 2022 May;
11(5).
PMID: 35631093
Background: The evidence in the medical literature regarding the prevalence of antibody towards SARS-CoV-2 in patients with chronic kidney disease is limited, particularly among those at the pre-dialysis stage. Aim:...
16.
Molinari P, Alfieri C, Mattinzoli D, Campise M, Cervesato A, Malvica S, et al.
Front Med (Lausanne)
. 2022 Apr;
9:821884.
PMID: 35360722
Renal transplantation (RTx) allows us to obtain the resolution of the uremic status but is not frequently able to solve all the metabolic complications present during end-stage renal disease. Mineral...
17.
Brescacin A, Iesari S, Guzzo S, Alfieri C, Darisi R, Perego M, et al.
Medicina (Kaunas)
. 2022 Jan;
58(1).
PMID: 35056389
Allograft vesicoureteral reflux (VUR) is a leading urological complication of kidney transplantation. Despite the relatively high incidence, there is a lack of consensus regarding VUR risk factors, impact on renal...
18.
Campise M, Alfieri C, Perego M, Tamborini F, Cresseri D, Gandolfo M, et al.
Pathogens
. 2021 Aug;
10(8).
PMID: 34451428
COVID-19 is a life-threatening infection among elderly patients, comorbid patients, or transplanted patients. Lombardy (region of Italy), accounts for 786,324 cases as of 21 April 2021. We retrospectively describe our...
19.
Alfieri C, Molinari P, Gandolfo M, Campise M, Cresseri D, Regalia A, et al.
Pathogens
. 2021 Apr;
10(4).
PMID: 33919676
The prevalence and the factors related to cytomegalovirus (CMV) disease (CMVd) during the 1st year of renal transplantation (RTx) and the relationship between CMVd and early and long-term graft and...
20.
Alfieri C, Mattinzoli D, Ikehata M, Cresseri D, Moroni G, Vaira V, et al.
Exp Mol Pathol
. 2020 Aug;
116:104516.
PMID: 32853636
Renal biopsy (RBx) is an essential tool in the diagnostic and therapeutic process of most native kidney diseases and in the renal transplanted graft. Laser capture microdissection (LCM), combined with...